These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 342089)
21. [Medullar aplasia due to concomitant use of azathioprine and allopurinol in kidney transplantation. Probable beneficial effects of infusion of leukemic cells]. Mocelin AJ; Hager ET; Carpenter CB; Merrill JP AMB Rev Assoc Med Bras; 1976 May; 22(5):165-6. PubMed ID: 788059 [No Abstract] [Full Text] [Related]
22. Granulocytic sarcoma after allogeneic bone marrow transplantation: a retrospective European multicenter survey. Acute and Chronic Leukemia Working Parties of the European Group for Blood and Marrow Transplantation. Békássy AN; Hermans J; Gorin NC; Gratwohl A Bone Marrow Transplant; 1996 May; 17(5):801-8. PubMed ID: 8733701 [TBL] [Abstract][Full Text] [Related]
23. Is azathioprine necessary in renal transplantation? Sheriff MH; Yayha T; Lee HA Lancet; 1978 Jan; 1(8056):118-20. PubMed ID: 87552 [TBL] [Abstract][Full Text] [Related]
24. Does mycophenolate mofetil increase the incidence of cytomegalovirus disease compared with azathioprine after cadaveric kidney transplantation? Basic-Jukic N; Kes P; Bubic-Filipi LJ; Puretic Z; Brunetta B; Pasini J Transplant Proc; 2005 Mar; 37(2):850-1. PubMed ID: 15848553 [TBL] [Abstract][Full Text] [Related]
30. Chronic granulocytic leukaemia in a patient with chronic renal failure on dialysis. Dodsworth H; Gabriel R J Clin Pathol; 1981 Jan; 34(1):58-9. PubMed ID: 6936403 [TBL] [Abstract][Full Text] [Related]
31. Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trial. Remuzzi G; Cravedi P; Costantini M; Lesti M; Ganeva M; Gherardi G; Ene-Iordache B; Gotti E; Donati D; Salvadori M; Sandrini S; Segoloni G; Federico S; Rigotti P; Sparacino V; Ruggenenti P J Am Soc Nephrol; 2007 Jun; 18(6):1973-85. PubMed ID: 17460145 [TBL] [Abstract][Full Text] [Related]
32. New approaches in chronic granulocytic leukemia--origin, prognosis, and treatment. Goldman JM; Lu DP Semin Hematol; 1982 Oct; 19(4):241-56. PubMed ID: 6130606 [No Abstract] [Full Text] [Related]
33. [Hepatic veno-occlusive disease associated to the use of azathioprine in a renal transplant recipient]. Hola K; Brahm J; Alvo M; Cotera A; Passalacqua W; Smok G Rev Med Chil; 1996 Dec; 124(12):1489-91. PubMed ID: 9334484 [TBL] [Abstract][Full Text] [Related]
34. Patient survival after renal transplantation; more than 25 years follow-up. Arend SM; Mallat MJ; Westendorp RJ; van der Woude FJ; van Es LA Nephrol Dial Transplant; 1997 Aug; 12(8):1672-9. PubMed ID: 9269647 [TBL] [Abstract][Full Text] [Related]
35. Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-up. Ducloux D; Motte G; Billerey C; Bresson-Vautrin C; Vautrin P; Rebibou JM; Saint-Hillier Y; Chalopin JM Transpl Int; 2002 Sep; 15(8):387-92. PubMed ID: 12221456 [TBL] [Abstract][Full Text] [Related]
36. The role of immunosuppression in the genesis and growth of malignant tumours. Reis HE Ger Med Mon; 1971; 1(1):16-21. PubMed ID: 4931500 [No Abstract] [Full Text] [Related]
37. Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study. Thierry A; Le Meur Y; Ecotière L; Abou-Ayache R; Etienne I; Laurent C; Vuiblet V; Colosio C; Bouvier N; Aldigier JC; Rerolle JP; Javaugue V; Gand E; Bridoux F; Essig M; Hurault de Ligny B; Touchard G Transpl Int; 2016 Jan; 29(1):23-33. PubMed ID: 26729582 [TBL] [Abstract][Full Text] [Related]
38. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction. Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092 [TBL] [Abstract][Full Text] [Related]
39. Outcome in cadaveric renal transplant recipients treated with cyclosporine A and mycophenolate mofetil versus cyclosporine A and azathioprine. Lee CM; Markezich AJ; Scandling JD; Dafoe DC; Alfrey EJ J Surg Res; 1998 May; 76(2):131-6. PubMed ID: 9698512 [TBL] [Abstract][Full Text] [Related]
40. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Opelz G; Henderson R Lancet; 1993 Dec 18-25; 342(8886-8887):1514-6. PubMed ID: 7902900 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]